Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;32(21):2921-9.
doi: 10.1002/elps.201100396. Epub 2011 Oct 17.

Blinded study determination of high sensitivity and specificity microchip electrophoresis-SSCP/HA to detect mutations in the p53 gene

Affiliations

Blinded study determination of high sensitivity and specificity microchip electrophoresis-SSCP/HA to detect mutations in the p53 gene

Christa N Hestekin et al. Electrophoresis. 2011 Nov.

Abstract

Knowledge of the genetic changes that lead to disease has grown and continues to grow at a rapid pace. However, there is a need for clinical devices that can be used routinely to translate this knowledge into the treatment of patients. Use in a clinical setting requires high sensitivity and specificity (>97%) in order to prevent misdiagnoses. Single-strand conformational polymorphism (SSCP) and heteroduplex analysis (HA) are two DNA-based, complementary methods for mutation detection that are inexpensive and relatively easy to implement. However, both methods are most commonly detected by slab gel electrophoresis, which can be labor-intensive, time-consuming, and often the methods are unable to produce high sensitivity and specificity without the use of multiple analysis conditions. Here, we demonstrate the first blinded study using microchip electrophoresis (ME)-SSCP/HA. We demonstrate the ability of ME-SSCP/HA to detect with 98% sensitivity and specificity >100 samples from the p53 gene exons 5-9 in a blinded study in an analysis time of <10 min.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no financial or commercial conflicts of interest.

Figures

Figure 1
Figure 1
Representative electropherograms of p53 exon 8 wild-type (a) and wild-type + mutant samples for an easily identified mutation (b) and a more challenging mutation (c), with the detection of the mutations highlighted by . Mutations were detected by tandem SSCP/HA on a microfluidic device using the following conditions: ambient temperature, 2-color laser induced fluorescence (LIF) detection ( for the forward strand, for the reverse strand), 0.1% PHEA dynamically coated channel, 350 V/cm applied electric field strength. Baselines adjusted to value of zero to remove background noise.
Figure 2
Figure 2
Electropherograms of p53 exon 8 demonstrating temporal stability of SSCP and HA conformers that allowed mutation detection for at least 16 days after initial heat denaturing and snap cooling when stored at 0–4 °C. Detection of the mutations by tandem SSCP/HA is highlighted by . Mutations were detected on a microfluidic device using the following conditions: ambient temperature, 2-color LIF detection ( for the forward strand, for the reverse strand), 0.1% PHEA dynamically coated channel, 350–450 V/cm applied electric field strength. Baselines adjusted to value of zero to remove background noise.
Figure 3
Figure 3
Electropherograms of p53 exons 5–9 wild-type and wild-type + mutant samples demonstrating ability to detect mutations at mutant DNA concentrations as low as 15–18% mutant DNA with detection of the mutations by tandem SSCP/HAhighlighted by . Mutations were detected on a microfluidic device using the following conditions: ambient temperature, 2-color LIF detection ( for the forward strand, for the reverse strand), 0.1% PHEA dynamically coated channel, 350–450 V/cm applied electric field strength. Baselines adjusted to value of zero to remove background noise.

Similar articles

Cited by

References

    1. Venter J, Adams M, Myers E, Li P, Mural R, Sutton G, Smith H, Yandell M, Evans C, Holt R, et al. Science. 2001;291:1304–1351. - PubMed
    1. Lander E, Linton L, Birren B, Nusbaum C, Zody M, Baldwin J, Devom K, Dewar K, Doyle M, FitzHugh W, et al. Nature. 2001;409:860–921. - PubMed
    1. Levine A, Momand J, Finlay C. Nature. 1991;351:453–456. - PubMed
    1. Lamb PaCL. Molecular and Cellular Biology. 1986;6:1379–1385. - PMC - PubMed
    1. Olivier M, Eeles R, Hollstein M, Khan M, Harris C, Hainaut P. Human Mutation. 2002;19:607–614. - PubMed

Publication types